v-Src-induced increases in diglyceride are derived from phosphatidylcholine via a type D phospholipase (PLD) and a phosphatidic acid phosphatase. v-Src-induced PLD activity, as measured by PLD-catalyzed transphosphatidylation of phosphatidylcholine to phosphatidylethanol, is inhibited by GDPIS, which inhibits G-protein-mediated intracellular signals. Similarly, v-Src-induced increases in diglyceride are also blocked by GDPISS. In contrast to the PLD activity induced by v-Src, PLD activity induced by the protein kinase C agonist, 12-0-tetradecanoylphorbol-13-acetate (TPA), was insensitive to GDPIIS. Consistent with the involvement of a G protein in the activation of PLD activity by v-Src, GTP-yS, a nonhydrolyzable analog of GTP that potentiates G-protein-mediated signals, strongly enhanced PLD activity in v-Src-transformed cells relative to that in parental BALB/c 3T3 cells. v-Src was dependent upon the presence of ATP but was unaffected by either cholera or pertussis toxin. These data suggest that v-Src induces PLD activity through a phosphorylation event and is mediated by a cholera and pertussis toxin-insensitive G protein.Cellular transformation involves the disruption of intracellular signaling mechanisms (see reference 12 for a review). Protein-tyrosine kinase activity is frequently an early event in the transduction of intracellular signals and has been extensively implicated in transformation tumorigenesis (12). The oncogenic protein-tyrosine kinase, v-Src, transforms cells because of a constitutively active kinase (22). As a result of this constitutively active kinase activity, v-Src activates multiple intracellular signaling mechanisms that lead to the induction of gene expression (17,41,43). Protein kinase C (PKC) is a serine/threonine-specific protein kinase that has been implicated in v-Src-induced intracellular signaling (20,38,43,45,51,53), although not all intracellular signals activated by v-Src involve PKC (41, 43). PKC is activated by the phospholipid metabolite diglyceride (DG) (37). DG is frequently generated by the phospholipase C-mediated hydrolysis of phosphatidylinositol 4,5-bisphosphate (see references 16 and 17 for a review); however, v-Src-induced increases in DG are derived from phosphatidylcholine (PC) via the action of a type D phospholipase (PLD) and a phosphatidic acid phosphatase (50). The activation of PLD by v-Src was found to be independent of PKC (48). Thus, it is likely that the DG produced by the PLD-phosphatidic acid phosphatase mechanism is responsible for the activation of PKC by v-Src. (18,31,33,34), epidermal growth factor (26, 27, 55), and colony-stimulating factor 1 (24, 25) receptors. G proteins have also been implicated in mediating the effects of c-Src on the ,-adrenergic response (11,36). We previously demonstrated that the activation of PKC-dependent gene expression and phosphorylation of the PKC substrate MARCKS by the related protein-tyrosine kinase v-Fps is dependent on a G protein (1). Since PKC is presumably the target of the PLDgenerated DG, these data su...